MicroRNA-21 Is a Downstream Effector of AKT That Mediates Its Antiapoptotic Effects via Suppression of Fas Ligand*

Overview of attention for article published in Journal of Biological Chemistry, April 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

patent: 6 patents

Readers on

mendeley: 176 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 6 patents that reference this research output.

Targeted delivery of an inhibitor of miR-21 to macrophages for the treatment of pulmonary…

Grant US-12618067-B2

United States of America

05 May 2026

Targeted delivery of miR-21 inhibitors to macrophages for the treatment of pulmonary…

Application KR-20230008741-A

Republic of Korea

16 Jan 2023

THE MIRNA-212/132 FAMILY AS A THERAPEUTIC TARGET

Application EP-4008786-A2

European Patent Office

08 Jun 2022

TARGETED DELIVERY OF AN INHIBITOR OF MIR-21 TO MACROPHAGES FOR THE TREATMENT OF PULMONARY…

Application WO-2021205032-A1

World Intellectual Property Organisation (WIPO)

14 Oct 2021

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 2 additional patents.